MedPath
HSA Approval

BAGEDA FILM-COATED TABLET 20MG

SIN17108P

BAGEDA FILM-COATED TABLET 20MG

BAGEDA FILM-COATED TABLET 20MG

October 8, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AA13

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

WORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş.

Active Ingredients

Leflunomide

20.000mg

Leflunomide

Documents

Package Inserts

Bageda Film-coated Tablet PI.pdf

Approved: October 8, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BAGEDA FILM-COATED TABLET 20MG - HSA Approval | MedPath